Journal of Otolaryngology-Head & Neck Surgery

Papers
(The H4-Index of Journal of Otolaryngology-Head & Neck Surgery is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
Prehabilitation in head and neck cancer patients: A literature review62
Canadian Rhinology Working Group consensus statement: Biologic therapies for chronic rhinosinusitis28
Extended high-frequency audiometry in healthy adults with different age groups26
Prognostic factors of head and neck cutaneous squamous cell carcinoma: A systematic review25
BRAFV600E mutation is associated with aggressive features in papillary thyroid carcinomas ≤ 1.5 cm21
Canadian real-world study of access and clinical results using dupilumab for chronic rhinosinusitis with polyps20
Readability and quality assessment of internet-based patient education materials related to nasal septoplasty20
The impact of close surgical margins on recurrence in oral squamous cell carcinoma19
Variability in instructions for performance of nasopharyngeal swabs across Canada in the era of COVID-19 – what type of swab is actually being performed?18
The prospective evaluation and risk factors of dysphagia after surgery in patients with oral cancer17
5-year outcomes of salvage endoscopic nasopharyngectomy for recurrent nasopharyngeal carcinoma17
Molecular testing for cytologically suspicious and malignant (Bethesda V and VI) thyroid nodules to optimize the extent of surgical intervention: A retrospective chart review15
Specimen oriented intraoperative margin assessment in oral cavity and oropharyngeal squamous cell carcinoma15
Management of sudden sensorineural hearing loss among primary care physicians in Canada: A survey study14
Mutational status may supersede tumor size in predicting the presence of aggressive pathologic features in well differentiated thyroid cancer14
Insight into the current practice of ototoxicity monitoring during cisplatin therapy14
0.039146900177002